Regardless of disease or cancer type, most GWAS studies have been performed on European populations.31 In glioma, the only non-European GWAS were conducted in East Asians, which identified three novel germline variants: in or near STK38L, RAB27A, and CYP4F12. This evidence concerns the gene STK38L and central nervous system cancer.